Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Persan Farma is a Spanish healthcare company focused on clinical and enteral nutrition products for patients who require specialized nutritional support. The company markets oral, tube-feeding, and modular nutrition solutions, with product families including NutAvant, SondAvant, HepatoNUTRIL, PeptiNUTRIL, NefroNUTRIL, NeoNUTRIL, and ProSUP, as well as CareAvant Oral for oral mucosal care. Its business is oriented toward supporting healthcare professionals with disease- and condition-specific nutritional products rather than traditional drug development. Persan Farma was acquired in 2022 by the Radesant group, which described the transaction as the purchase of 100% of the Persan Farma business. The company remains active as a commercial brand in Spain and is positioned around science-backed clinical nutrition and professional education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Persan Farma.